Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: mostly (40), largely (66), chiefly (1), primarily (85), principally (11), generally (218)

Phototesting - patient information

Description: This factsheet explains what phototesting is and what happens before, during, and after your appointment.
Url: /Media/UHS-website-2019/Patientinformation/Skin/Phototesting-1527-PIL.pdf

Laryngeal papilloma - patient information

Description: This factsheet explains what laryngeal papilloma is, how it can affect you and what the available treatment options are.
Url: /Media/UHS-website-2019/Patientinformation/Ear-nose-and-throat/Laryngeal-papilloma-4001-PIL.pdf

Vestibular migraine - patient information

Description: This factsheet explains what a vestibular migraine is, what causes a migraine and how it is treated.
Url: /Media/UHS-website-2019/Patientinformation/Audiology/Vestibular-migraine-2564-PIL.pdf

Peripheral plasma exchange - patient information

Description: This factsheet is a guide to having plasma exchange treatment.
Url: /Media/UHS-website-2019/Patientinformation/Blooddisorders/Peripheral-plasma-exchange-1587-PIL.pdf

Regorafenib

Description: Chemotherapy Protocol Gastro-Intestinal Stromal Tumour Regorafenib Regimen • GIST – Regorafenib Indication • Regorafenib is recommended for histologically
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Regorafenib.pdf

Regorafenib

Description: Chemotherapy Protocol Hepatocellular Cancer Regorafenib Regimen • Hepatocellular – Regorafenib Indication • Regorafenib is recommended as an option for tre
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Regorafenib.pdf

NilotinibChronic

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (chronic phase) Regimen • CML – Nilotinib (chronic phase) Indication • As an option for the tre
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibChronic.pdf

NilotinibAccelerated

Description: Chemotherapy Protocol Chronic Myeloid Leukaemia Nilotinib (accelerated phase) Regimen • CML – Nilotinib (accelerated phase) Indication • Nilotinib is an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/NilotinibAccelerated.pdf

Impaired glucose tolerance in cystic fibrosis - patient information

Description: This factsheet is about impaired glucose tolerance (IGT) in people with cystic fibrosis (CF).
Url: /Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Impaired-glucose-tolerance-in-cystic-fibrosis-2636-PIL.pdf

BRC Research Theme Lead JD and PS

Description: National Institute for Health Research Southampton Biomedical Research Centre : NIHR BRC Theme Lead National Institute for Health Research (NIHR) B
Url: /Media/Southampton-Clinical-Research/Downloads/BRC-Research-Theme-Lead-JD-and-PS.doc

41 to 50 of 91

Previous … 3 4 5 6 7 … Next